Tandem Diabetes Care Inc. (TNDM)

63.58
NASDAQ : Health Technology
Prev Close 69.08
Day Low/High 62.65 / 68.86
52 Wk Low/High 17.50 / 74.81
Avg Volume 1.69M
Exchange NASDAQ
Shares Outstanding 58.07M
Market Cap 4.01B
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a Company update at the following upcoming investor conferences: Bank of America Merrill Lynch Healthcare...

Tandem Diabetes Care Announces First Quarter 2019 Financial Results And Updated 2019 Financial Guidance

Tandem Diabetes Care Announces First Quarter 2019 Financial Results And Updated 2019 Financial Guidance

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2019 and updated its financial guidance for the year ending December 31, 2019.

DexCom, HCA Healthcare, Tractor Supply: 'Mad Money' Lightning Round

DexCom, HCA Healthcare, Tractor Supply: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at DexCom, HCA Healthcare, Tractor Supply, Sarepta Therapeutics, The Blackstone Group, HNI Corp. and more.

Investing's Not a Game: Cramer's 'Mad Money' Recap (Thursday 4/25/19)

Investing's Not a Game: Cramer's 'Mad Money' Recap (Thursday 4/25/19)

Jim Cramer says it's the start CNBC's annual Stock Draft Contest, but he cautions Mad Money viewers that although investing can be fun, it requires discipline and doing your homework.

Tandem Diabetes Care To Announce First Quarter 2019 Financial Results On April 30, 2019

Tandem Diabetes Care To Announce First Quarter 2019 Financial Results On April 30, 2019

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2019 results after the financial markets close on Tuesday, April 30, 2019.

Bankers on the Grill: Cramer's 'Mad Money' Recap (Wednesday 4/10/19)

Bankers on the Grill: Cramer's 'Mad Money' Recap (Wednesday 4/10/19)

Averages barely budge, despite grilling of banking CEOS by lawmakers. Jim Cramer talks about earnings and the great divide in Washington.

Yeti holdings, Tandem Diabetes, Electronic Arts: 'Mad Money' Lightning Round

Yeti holdings, Tandem Diabetes, Electronic Arts: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Yeti holdings, Tandem Diabetes Care, Electronic Arts, Aurora Cannabis, PacWest Bancorp and more.

What More Do They Want?: Cramer's 'Mad Money' Recap (Monday 3/25/19)

What More Do They Want?: Cramer's 'Mad Money' Recap (Monday 3/25/19)

Apple couldn't do much to hold back the bears today, but Jim Cramer says the company's services segment is the most important thing and he's more than happy with it.

Jim Cramer: Blockbuster Ideas That I Know Would Move Apple's Needle

Jim Cramer: Blockbuster Ideas That I Know Would Move Apple's Needle

What would the people who help determine AAPL's stock price really want?

Playbook for the Fed: Cramer's 'Mad Money' Recap (Thursday 3/21/19)

Playbook for the Fed: Cramer's 'Mad Money' Recap (Thursday 3/21/19)

Jim Cramer has a playbook for finding the stocks that can make money without the economy filling the sails.

Berkshire Hathaway, Callaway Golf, Microsoft: 'Mad Money' Lightning Round

Berkshire Hathaway, Callaway Golf, Microsoft: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Berkshire Hathaway, Callaway Golf, Whitestone, Microsoft, Centene and more.

Jim Cramer Won't Buy Apple Stock at Current Prices Unless the Company Does This

Jim Cramer Won't Buy Apple Stock at Current Prices Unless the Company Does This

The stock is just too expensive here ... unless the company buys these two medical-devices companies.

Look Out for an Intraday Reversal in the Market

Look Out for an Intraday Reversal in the Market

Some momentum movers are becoming extended and have seen profit-taking Monday.

Disrupt or Be Disrupted: Cramer's 'Mad Money' Recap (Wednesday 3/13/19)

Disrupt or Be Disrupted: Cramer's 'Mad Money' Recap (Wednesday 3/13/19)

Disruptors are among the biggest winners, says Jim Cramer. Companies like Apple and Kraft Heinz need to re-imagine their companies in bold, meaningful and even radical ways.

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

In this day and age, companies must be 'disruptors' or get left in the dust.

Tandem Diabetes Care Approved As Insulin Pump Vendor For ADP In Ontario, Canada

Tandem Diabetes Care Approved As Insulin Pump Vendor For ADP In Ontario, Canada

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it is now registered as an approved vendor of insulin pumps and supplies under the Assistive Devices Program (ADP) in Ontario,...

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan, president and chief executive officer, will present at the following upcoming investor conferences: Cowen 39 th...

Tandem Diabetes Care Announces Plan To Use Remote Software Update Tool In Ongoing Clinical Trial

Tandem Diabetes Care Announces Plan To Use Remote Software Update Tool In Ongoing Clinical Trial

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it intends to use its remote software update tool, the Tandem Device Updater, to resolve a Control-IQ technology software anomaly...

A Technical Strategy for Tandem Diabetes Care

A Technical Strategy for Tandem Diabetes Care

Are we late to the game with the stock up so much?

Your Game Plan: Cramer's 'Mad Money' Recap (Friday 3/1/19)

Your Game Plan: Cramer's 'Mad Money' Recap (Friday 3/1/19)

Jim Cramer has your game plan for next week: Keep a sharp eye out for the Fed and the employment data.

Tandem Diabetes Care Announces Succession Plan For Chief Executive Officer And Board Of Directors

Tandem Diabetes Care Announces Succession Plan For Chief Executive Officer And Board Of Directors

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced a succession plan for its chief executive officer (CEO) and select members of its board of directors.

Tandem Diabetes Care Reports 2018 Financial Results And 2019 Financial Guidance

Tandem Diabetes Care Reports 2018 Financial Results And 2019 Financial Guidance

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2018 and financial guidance for the year ending December 31, 2019.

Tandem Diabetes Care Appoints New Senior Vice President To Drive Expansion Of Digital Health And Information Technology Initiatives

Tandem Diabetes Care Appoints New Senior Vice President To Drive Expansion Of Digital Health And Information Technology Initiatives

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Manuel Jaime as its new Senior Vice President, Technology and Digital Health.

T:slim X2 Insulin Pump First To Receive New ACE Pump Classification By FDA

T:slim X2 Insulin Pump First To Receive New ACE Pump Classification By FDA

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that the U.

Tandem Diabetes Care To Announce Fourth Quarter And Full Year 2018 Financial Results On February 26, 2019

Tandem Diabetes Care To Announce Fourth Quarter And Full Year 2018 Financial Results On February 26, 2019

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2018 results after the financial markets close on Tuesday, February 26, 2019.

Take-Two Interactive, Cliffs Natural Resources: 'Mad Money' Lightning Round

Take-Two Interactive, Cliffs Natural Resources: 'Mad Money' Lightning Round

Jim Cramer takes a look at Take-Two Interactive, Sina, Cliffs Natural Resources, Public Service Enterprise, Annaly Capital, Neutral Tandem and more.

From Bear Back to Bull: Cramer's 'Mad Money' Recap (Thursday 1/10/19)

From Bear Back to Bull: Cramer's 'Mad Money' Recap (Thursday 1/10/19)

Jim Cramer says it looks like the bulls are no longer fighting the Fed or the tape.

Tandem Diabetes Care Announces Appointment Of Rebecca Robertson As Board Member

Tandem Diabetes Care Announces Appointment Of Rebecca Robertson As Board Member

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Rebecca (Beckie) Robertson was appointed as an independent member of its board of directors.

TheStreet Quant Rating: D- (Sell)